Accelerating the digital revolution in life sciences.

Featured company

NewLimit

Treating age-related disease to extend human healthspan.

learn more

Featured company

Enveda Biosciences

Unlocking the planet's chemistry to discover next-generation therapies

learn more

Featured company

Kaleidoscope Bio

Software to supercharge how scientific teams collaborate, manage experiments, and track decision-making

learn more

Featured company

Recursion

Recursion's mission is to decode biology to radically improve lives by advancing a biological discovery platform at the speed of technology platforms.

learn more

Portfolio companies

We partner with entrepreneurs, academics, and engineers to turn their groundbreaking ideas into dominant businesses that span the tech and bio ecosystem.

Enveda Biosciences

Unlocking the planet's chemistry to discover next-generation therapies

Kaleidoscope Bio

Software to supercharge how scientific teams collaborate, manage experiments, and track decision-making

NewLimit

Treating age-related disease to extend human healthspan.

Lamin

Open-source software infrastructure for the modern lab

Stealth

Biologics Manufacturing Platform

Substack: Dimension Research

Building out a research practice at Dimension.

Fortune

Coinbase founder Brian Armstrong raises $40 million for NewLimit, a startup that wants to ‘cure aging’

TechCrunch

NewLimit, cofounded by Coinbase CEO Brian Armstrong, raises $40M to extend life

NewLimit Blog

NewLimit has secured $40 million in Series A funding from Dimension, Founders Fund, and Kleiner Perkins with participation from Eric Schmidt, Elad Gil, Garry Tan, and Fred Ehrsam

Dead Cat Podcast

I wanted to hear why Goulburn and Dar, general partners at Lux Capital, and Li, a general partner at Obvious Ventures, decided to embark on the long, hard trek of building their own firm.

New York Bio

NewYork BIO's breakfast series has gone virtual! Providing engaging speakers on innovation, clinical development, patient engagement and more cutting topics across the biopharmaceutical industry.

Homeroom Podcast

Adam Goulburn is the co-founder and Managing Partner of Dimension, a $300 million fund focused on investing in companies at the intersection of medicine and data science.

Wall Street Journal

New VC Firm Dimension Gets $350 Million as Healthcare Venture Fundraising Remains High

Fortune

Three venture investors weigh in on the future of biotech as they launch a new $350M fund

BioSpace

As Tech Giants Fall, Tech-Focused VC Fund Rakes in $350M

Fierce Biotech

Creating a new dimension: Biotech VC merging tech and life sciences unveils with $350M

BioPharma Dive

Three VCs launch Dimension, a new firm with plans to fuel biotech’s ‘digitization’

STAT

Focused exclusively on life sciences, three top investors set out on their own

Endpoints

‘Siloing is just so outdated’: New $350M VC fund aims to digitize life sciences

Timmerman Report

Dimension Debuts With 350M To Back Startups That Digitize Biology

Forbes

These Venture Veterans Have Launched A $350 Million Fund Aimed At Digitizing Life Sciences

Metadata: The 'How' and 'Why' Behind Your Science

Endpoints

Enveda secures $68M to move revised pipeline into the clinic in 2023

MedCity News

Here’s a look at natural product drug discovery 2.0

Endpoints

'Structure, beauty and clarity': With seed financing, Kaleidoscope aims to synchronize R&D teams

AlleyWatch

Kaleidoscope Raises $6M for its Collaboration Platform for Research Science Teams

Accelerating the digital revolution in life sciences.

Featured company

NewLimit

Featured company

Enveda Biosciences

Featured company

Kaleidoscope Bio

Featured company

Recursion

Portfolio companies

Enveda Biosciences

Kaleidoscope Bio

NewLimit

Lamin

Stealth

Search open roles at our portfolio companies